Study will use innovative technology to focus on neurodegenerative diseases
Cedrus' Chairman, Mr. Rani Jarkas said, "We have seen growing interest from Chinese enterprises and investors to acquire life sciences technologies and products overseas, and the increased desire of Australian life science companies to build a presence in China, the second-largest biopharma market in the world."
Specialty therapy management company will host a webinar to explore current trends and provide actionable insights for pharmacy leaders
Quattro Rx labels video
Increasing Number of Disabled Patients to Drive Growth Prospects for Robotic Rehabilitation and Assistive Technologies
Luxury hair care brand now operating in Chinese eCommrce market
Investment Adds New Capabilities and State-of-the-Art Responsible Care Environment
Launches preclinical development effort of LBT-3627 as a neuroprotective/repair treatment for Multiple Sclerosis
United States Pharmacopeia
Visit Centurion at the Michigan Society of Health-System Pharmacists (MSHP) Annual Meeting, October 27, East Lansing, MI
Strand NGS now supports large scale RNA- and small-RNA-Seq and Unique Molecular Identifiers (UMIs) for DNA-, RNA-, and small-RNA-Seq.
The study compared the effect of ACT-101 to placebo and anti-TNFα the most effective therapy in a model of colitis induced by TNBS.
Visit Centurion at the Michigan Society of Health-System Pharmacists (MSHP) Annual Meeting, October 27, East Lansing, MI and discover how alcohol-resistant Quattro™ and SelfShred Plus™ IV labels protect patient health information.